Characteristics | SHR | P | SHR | P |
---|---|---|---|---|
LNR classification | ||||
LNR1 | 1(Reference) | |||
LNR2 | 1.56 (1.47–1.67) | < 0.001 | ||
LNR3 | 2.54 (2.30–2.80) | < 0.001 | ||
N stage | ||||
N1 | 1 (Reference) | |||
N2 | 1.54 (1.45–1.63) | < 0.001 | ||
N3 | 2.81 (2.32–3.41) | < 0.001 | ||
Sex | ||||
Female | 1(Reference) | 1(Reference) | ||
Male | 1.23 (1.16–1.30) | < 0.001 | 1.21 (1.134–1.29) | < 0.001 |
Race | ||||
White | 1(Reference) | 1(Reference) | ||
Black | 0.94 (0.85–1.05) | 0.262 | 0.97 (0.87–1.07) | 0.506 |
Others | 0.90 (0.81–1.00) | 0.040 | 0.88 (0.79–0.98) | 0.020 |
Primary site | ||||
Upper lobe | 1(Reference) | 1(Reference) | ||
Lowerlobe | 1.08 (1.01–1.15) | 0.018 | 1.11 (1.04–1.18) | 0.001 |
Mainbronchus | 1.20 (0.96–1.49) | 0.103 | 1.21 (0.98–1.51) | 0.083 |
Middlelobe | 0.93 (0.81–1.06) | 0.290 | 1.03 (0.91–1.18) | 0.625 |
Overlapping/NOS | 1.28 (1.10–1.49) | 0.001 | 1.30 (1.12–1.52) | < 0.001 |
Grade | ||||
I/II | 1(Reference) | 1(Reference) | ||
III/IV | 1.23 (1.16–1.31) | < 0.001 | 1.25 (1.18–1.33) | < 0.001 |
Histology | ||||
Adenocarcinoma | 1(Reference) | 1(Reference) | ||
Squamous | 0.92 (0.86–0.99) | 0.91 (0.84–0.97) | 0.008 | |
Others | 1.15 (1.05–1.25) | 0.002 | 1.14 (1.04–1.24) | 0.003 |
T stage | 0.030 | |||
T1 | 1(Reference) | |||
T2 | 1.32 (1.23–1.412) | < 0.001 | 1.29 (1.199–1.38) | < 0.001 |
T3 | 1.85 (1.62–2.12) | < 0.001 | 1.78 (1.56–2.04) | < 0.001 |
T4 | 1.82 (1.64–2.01) | < 0.001 | 1.82 (1.64–2.01) | < 0.001 |